WorkingGroup/GCP-Quality Assurance-Monitoring
This working group is devoted to all activities referring to quality management in clinical drug research and development. It is also a discussion forum which allows to communicate all GCP related issues. Special attention is directed at national and European regulations for clinical trials. The group particularly deals with the interpretation and implementation of new GCP requirements and comments on its application in clinical drug research. Exchange of information and practical experience is another focal point of this working group.
The group meets regularly every 3 to 4 months.
If you have questions please contact:
Dr. Kerstin König
Associate Vice President Global Clinical Quality Assurance
ImClone Systems International GmbH
Am Taubenfeld 21/2
69123 Heidelberg
Tel: 0049 6221 70509 60
Fax: 0049 6221 70509 99
eMail: kerstin.koenig@imclone.com
Working Group "GCP-Quality Management"
Welcome to the "GCP: Quality Assurance/Monitoring" Working Group:
This working group is devoted to all activities referring to quality management in clinical drug research and development. It is also a discussion forum which allows to communicate all GCP related issues. Special attention is directed at national and European regulations for clinical trials. The group particularly deals with the interpretation and implementation of new GCP requirements and comments on its application in clinical drug research. Exchange of information and practical experience is another focal point of this working group.
The group meets regularly every 3 to 4 months.
If you have questions please contact:
Dr. Kerstin König
Associate Vice President Global Clinical Quality Assurance
ImClone Systems International GmbH
Am Taubenfeld 21/2
69123 Heidelberg
Tel: 0049 6221 70509 60
Fax: 0049 6221 70509 99
eMail: kerstin.koenig@imclone.com
Mitglieder-Login
DGGF Infoblatt 01/2012
